Filing Details
- Accession Number:
- 0001144204-10-000465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-05 12:00:00
- Reporting Period:
- 2010-01-02
- Filing Date:
- 2010-01-05
- Accepted Time:
- 2010-01-05 20:03:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434718 | Iii F James Oliviero | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-02 | 100,000 | $0.00 | 462,964 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2010-01-05 | 22,981 | $2.60 | 439,983 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The 100,000 shares are restricted common stock, with one-third of the 100,000 shares vesting on January 2, 2011, and one-twelfth vesting on each of April 2, 2011, July 2, 2011, October 2, 2011, January 2, 2012, April 2, 2012, July 2, 2012, October 2, 2012, and January 2, 2013.
- Sale of a total of 22,981 shares of common stock was made in order to satisfy Mr. Oliviero's income tax withholding obligation upon the vesting of 105,833 shares of restricted stock.
- The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- 324,167 shares of the 439,983 shares are restricted common stock.
Billionaire Hedge Funds
